logo

For the Inventor, By the Inventor

Kingston Springs, TN, United States of America

Rocco D Gogliotti

USPTO Granted Patents = 12 

Average Co-Inventor Count = 7.7

ph-index = 6

Forward Citations = 87(Granted Patents)


Company Filing History:

goldMedal12 out of 1,155 
 
Vanderbilt University
 patents
silverMedal1 out of 3,385 
 
University of Michigan
 patents
where one patent can have more than one assignee

Years Active: 2014-2024

Loading Chart...
12 patents (USPTO):Explore Patents
1. 11999716 - WDR5 inhibitors and modulators (2024-06-04),
2. 10844044 - WDR5 inhibitors and modulators (2020-11-24),
3. 10807959 - WDR5-MLL1 inhibitors and modulators (2020-10-20),
4. 10160763 - WDR5 inhibitors and modulators (2018-12-25),
5. 9212180 - Menin-MLL inhibitors and methods of use thereof (2015-12-15),
6. 9192603 - Heterocyclic sulfone mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction (2015-11-24),
7. 9180192 - mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction (2015-11-10),
8. 9163015 - Pyrazolopyridine, pyrarolopyrazine, pyrazolopyrimidine, pyrazolothiophene and pyrazolothiazole compounds as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction (2015-10-20),
9. 9108963 - Pyrazolopyridine, pyrazolopyrazine, pyrazolopyrimidine, pyrazolothiophene and pyrazolothiazole compounds as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction (2015-08-18),
10. 8779157 - MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction (2014-07-15),
11. 8697691 - Alkyl 3-((2-amidoethyl)amino)-8-azabicyclo[3.2.1]octane-8-carboxylate analogs as selective M1 agonists and methods of making and using same (2014-04-15),
12. 8658650 - Substituted 1,1,3,1-tetraoxidobenzo[D][1,3,2]dithiazoles as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction (2014-02-25),

Title: Rocco D Gogliotti: Innovator in WDR5 Inhibitors

Introduction

Rocco D Gogliotti is a prominent inventor based in Kingston Springs, TN (US), known for his significant contributions to the field of pharmaceutical sciences. With a total of 12 patents to his name, Gogliotti has made remarkable strides in developing compounds that target critical protein interactions.

Latest Patents

Among his latest innovations are the WDR5 inhibitors and modulators, which include isoquinolinone compounds and derivatives. These compounds are designed to inhibit WDR5 and associated protein-protein interactions, proving useful in treating disorders such as cancer cell proliferation. Another notable patent involves imino-azacycle-benzamide compounds that also inhibit WDR5, along with pharmaceutical compositions that utilize these compounds for therapeutic applications.

Career Highlights

Gogliotti has had a distinguished career, working with esteemed institutions such as Vanderbilt University and the University of Michigan. His research has focused on developing innovative solutions to complex medical challenges, particularly in the realm of cancer treatment.

Collaborations

Throughout his career, Gogliotti has collaborated with notable professionals in his field, including P Jeffrey Conn and Craig William Lindsley. These partnerships have further enhanced his research and contributed to the advancement of his patented technologies.

Conclusion

Rocco D Gogliotti stands out as a key figure in the development of WDR5 inhibitors, with a strong portfolio of patents that reflect his innovative spirit and dedication to improving healthcare outcomes. His work continues to influence the pharmaceutical landscape significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…